Please check your internet connection and try again.
# Hepamerz (l-Ornithine l-Aspartate)
## Overview
Hepamerz is a combination of the amino acids l-ornithine and l-aspartate. It is thought to reduce elevated ammonia levels in the blood by promoting its conversion to urea and glutamine in the liver and peripheral tissues.
## Primary Indications
Treatment of latent and manifest hepatic encephalopathy (HE) associated with cirrhosis.
## Adult Dosing
* **Oral:** 3 to 6 grams three times daily. The total daily dose should not exceed 18 grams.
* **Intravenous (IV):** 5 to 10 grams twice daily, administered as an infusion over 30-60 minutes. Maximum IV dose is typically 20 grams per day, but local protocols may vary.
## Pediatric Dosing
Data on pediatric use is limited. Dosing should be individualized and based on the severity of the condition and patient response.
## Dose Adjustments
No specific dose adjustments are routinely recommended for renal or hepatic impairment, as the drug is intended for patients with liver disease. However, careful monitoring is essential.
## Contraindications
* Known hypersensitivity to l-ornithine or l-aspartate.
* Severe renal insufficiency (creatinine clearance < 25 mL/min) may warrant caution due to potential accumulation.
## Adverse Effects
Generally well-tolerated.
* Gastrointestinal: Nausea, vomiting, abdominal pain, diarrhea.
* Other: Dizziness, headache, fatigue, skin rash.
## Key Drug Interactions
No significant drug interactions have been clearly established.
## Monitoring
* Serum ammonia levels.
* Neurological status (mental status, asterixis).
* Renal function.
## Clinical Pearls
* Hepamerz is most effective when ammonia levels are elevated.
* For oral administration, it can be mixed with water, juice, or tea.
* IV administration is generally used for more acute or severe presentations of HE.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the official prescribing information and relevant clinical guidelines for the most current and comprehensive drug information before making any treatment decisions.*